最高の肝転移医師 - トップ75名の医師

腫瘍生物学・免疫学および全身療法（免疫療法・分子標的療法）に関する査読付き論文を40本以上執筆し、トルコ腫瘍内科学会およびEuropean Head & Neck Societyの会員である。

患者がビュレント・カラゴズ医師を選ぶ理由：

• アナドル病院と米国の主要医療センターであるジョンズ・ホプキンス・メディシンとの戦略的提携のもと、米国の診療プロトコルに基づいた治療を提供。
• 腫瘍生物学・免疫学および全身療法（免疫療法・分子標的療法）に関する査読付き論文40本以上を執筆。
• 元診療部長（GATA）および教授・学科長（Okan大学、トルコ）として、主要医療センターにおける管理・臨床両面での豊富な経験を有する。
• 乳癌、肺癌、大腸癌などの固形腫瘍を対象に、腫瘍生物学に基づいた最新の治療レジメンを実施。
• アナドル病院はESMO認定およびJCI認定を取得しており、国際的なプロトコルに従い、多職種チームによる連携のもと、厳格な安全管理のもとで治療を提供。

エダ・タンリクル医師はアナドル医療センターの腫瘍内科を統括しており、21年の経験の経験を持つがん治療の専門家です。

• 腫瘍内科専門分野においてトルコ国内第3位にランクされている
• ハイダルパシャ・ヌムネ研修研究病院にて腫瘍内科部門を主導した
• 国際臨床試験における副研究者および主任研究者を務めた
• 腫瘍内科および化学療法を専門とする

900件以上の処置実績 – Solak医師はHisar Hospital Intercontinentalにて複雑ながん症例を専門としています。

• 腫瘍学における20年の経験の経験
• Hacettepe大学がん研究所にてフェローシップ研修を修了
• MDアンダーソンがんセンターでの臨床経験
• 乳がん、肺がん、消化器がんを専門とする

Peker教授は、Hisar Hospital Intercontinentalにて肝胆膵手術を専門とし、200例以上の肝臓手術を執刀しています。

• メイヨークリニックにて肝胆膵外科のトレーニングを修了
• Bakırköy Dr. Sadi Konuk病院における肝胆膵外科ユニットの創設者
• 肝臓癌外科および膵臓疾患を専門とする
• 400例以上の膵臓癌および胃癌手術を執刀

ワフィイ・アタライ医師は、17年の経験を持つ熟練した腫瘍外科医および一般外科医です。膵臓、結腸・直腸、肝臓に対する手術を専門とし、高度な内視鏡的処置も実施しています。国内外の学術誌に31本の論文を発表し、医学文献に多大な貢献をしています。

第20回学術大会における研究論文コンテストで第1位を受賞したほか、第5回外科学会議においても最優秀研究賞を受賞しています。TSS、パレスチナ医師会、およびIOAの会員として活動しており、これらの組織への積極的な参加は、外科分野における継続的な専門的成長と卓越性への取り組みを示しています。

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

ガレニア病院において肝転移を専門とする外科腫瘍学専門医であり、メキシコの主要医療機関で研鑽を積んでいます。

• CONACEMによる認定を取得し、2030年まで有効な資格を保有
• メキシコ腫瘍学会（SMEO）会員
• 2020年よりアナワク医科大学にて大学教員を務める
• IMSS（メキシコ社会保障機構）にて外科研修を修了

ペレス・シャロン医師は、ソウラスキー医療センターの消化器腫瘍研究所を率いており、肝転移治療の分野における第一人者です。

• 消化器癌の全身療法を専門とする
• ロンドンのロイヤル・マーズデン癌センターにて腫瘍学の研修を修了
• 膵腺癌の治療における新手法を開発
• 胆管腫瘍に関する分子生物学的研究において画期的な成果を挙げる

メリムスキー教授は、イスラエル屈指のがん専門医療機関であるスーラスキー医療センターにて、軟部組織・骨腫瘍科を主宰しています。

• 整形外科腫瘍学における41年の経験以上の専門的診療経験
• パリのギュスターヴ・ルシ研究所にて肉腫治療のフェローシップを修了
• ワイツマン科学研究所およびテルアビブ大学の上席研究員
• ESMOの肉腫専門委員会のアクティブメンバー
• がん治療成績に関する多数の研究論文を発表

ザイフェルト医師はゾーリンゲンの乳がんセンターを率い、26年の経験以上にわたり乳房温存手術と審美的再建を専門としています。

• 早期診断および革新的治療の専門家
• 形成再建技術に精通
• 治療全体を通じて心理的サポートを提供
• ゾーリンゲンを代表する乳がんセンターの一つを統括

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

トルコの腫瘍内科試験で第1位を獲得 – ケスキン医師はメモリアル・シシリにおける肝転移治療に25年の経験の専門的経験をもたらします。

• 900件以上の腫瘍学的処置を実施
• 第19回全国がん学会にてベストポスター賞を受賞
• ASCOおよびESMOの会員として国際的なプロトコルの最新情報を把握
• 化学療法、分子標的療法、免疫療法を専門とする